Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 5/20 | 0.68 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.49 |
| ▸ | DRD2 | P14416 | 1/20 | 0.46 |
| ▸ | DRD4 | P21917 | 1/20 | 0.46 |
| ▸ | DRD3 | P35462 | 1/20 | 0.46 |
| ▸ | CCR1 | P32246 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15862739 | 0.91 | OPRM1 (0.64) | OPRM1MAP4K4DRD2DRD4DRD3 | |
| SCHEMBL2218 | 0.91 | OPRM1 (0.64) | OPRM1MAP4K4DRD2DRD4DRD3 | |
| SCHEMBL1074339 | 0.90 | OPRM1 (0.62) | OPRM1MAP4K4DRD2DRD4DRD3 | |
| SCHEMBL31441141 | 0.90 | OPRM1 (0.62) | OPRM1MAP4K4DRD2DRD4DRD3 | |
| SCHEMBL2301089 | 0.88 | OPRM1 (0.60) | OPRM1MAP4K4DRD2DRD4DRD3 | |
| SCHEMBL625403 | 0.86 | OPRM1 (0.58) | OPRM1MAP4K4DRD2DRD4DRD3 | |
| SCHEMBL651535 | 0.86 | OPRM1 (0.58) | OPRM1MAP4K4DRD2DRD4DRD3 | |
| Hydrochloric Acid SCHEMBL1001869 | 0.85 | OPRM1 (0.61) | OPRM1MAP4K4DRD2DRD4DRD3 | |
| SCHEMBL11073259 | 0.85 | OPRM1 (0.57) | OPRM1MAP4K4DRD2DRD4DRD3 | |
| SCHEMBL20972063 | 0.84 | OPRM1 (0.56) | OPRM1MAP4K4DRD2DRD4DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4859232-A | Substituted-aryl cyclopropanecarbonitriles and derivatives thereof as herbicide antidotes | MONSANTO COMPANY (US) | 1989-08-22 | — | — | US | claimed |
| WO-2025136811-A1 | CHEMICAL COMPOUNDS AND USES THEREOF | IDEAYA BIOSCIENCES, INC. (US) | 2025-06-26 | — | — | WO | disclosed |
| EP-4305026-B1 | ANTI-INFLAMMATORY CARBOXAMIDE DERIVATIVES | BIOMEDCODE HELLAS SA (GR) | 2025-05-07 | — | — | EP | disclosed |
| US-20240317686-A1 | RORyT MODULATOR, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. (CN) | 2024-09-26 | — | — | US | disclosed |
| EP-4273129-A1 | RORgammaT MODULATOR, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Shanghai Pharmaceuticals Holding Co., Ltd. (CN) | 2023-11-08 | — | — | EP | disclosed |
| EP-4273129-A1 | RORgammaT MODULATOR, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Shanghai Pharmaceuticals Holding Co., Ltd. (CN) | 2023-11-08 | — | — | EP | disclosed |
| CN-116554066-A | Method for synthesizing N- (hetero) aryl sulfonamide compound | 陕西师范大学 | 2023-08-08 | — | — | CN | disclosed |
| WO-2022143771-A1 | RORγT MODULATOR, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 上海医药集团股份有限公司 | 2022-07-07 | — | — | WO | disclosed |
| WO-2022143771-A1 | RORγT MODULATOR, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 上海医药集团股份有限公司 | 2022-07-07 | — | — | WO | disclosed |
| CN-114685363-A | ROR gamma t regulator, preparation method and application thereof | 上海医药集团股份有限公司 | 2022-07-01 | — | — | CN | disclosed |
| US-6114532-A | ANTICOAGULANT | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2000-09-05 | — | — | US | disclosed |
| WO-2000001704-A2 | BENZIMIDAZOLES, PRODUCTION THEREOF AND USE THEREOF AS MEDICAMENTS | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2000-01-13 | — | — | WO | disclosed |
| US-5998673-A | ENANTIOMORPHS; BROMINATION 4-ARYL-3-FLUORO-2-BUTEN-1-OL; REACTING WITH ARYLBORONIC ACID IN PRESENCE OF A CATALYST | AMERICAN CYANAMID COMPANY (US) | 1999-12-07 | — | — | US | disclosed |
| WO-1999040072-A1 | FIVE-MEMBERED, BENZO-CONDENSED HETEROCYCLES USED AS ANTITHROMBOTIC AGENTS | BOEHRINGER INGELHEIM PHARMA KG (DE) | 1999-08-12 | — | — | WO | disclosed |
| EP-0934283-A2 | ARTHROPODICIDAL AND FUNGICIDAL CYCLIC AMIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1999-08-11 | — | — | EP | disclosed |
| EP-0933027-A1 | Methods and compositions for protecting animals and humans against attack and infestation by arthropod and helminth parasites | American Cyanamid Company (US) | 1999-08-04 | — | — | EP | disclosed |
| US-5849958-A | 1,4,diaryl-2-fluoro-2-butene insecticidal and acaricidal agents | AMERICAN CYANAMID COMPANY (US) | 1998-12-15 | — | — | US | disclosed |
| WO-1998005652-A2 | ARTHROPODICIDAL AND FUNGICIDAL CYCLIC AMIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1998-02-12 | — | — | WO | disclosed |
| EP-0811593-A1 | 1,4-diaryl-2-fluoro-2-butene insecticidal and acaricidal agents | American Cyanamid Company (US) | 1997-12-10 | — | — | EP | disclosed |
| US-4859232-A | Substituted-aryl cyclopropanecarbonitriles and derivatives thereof as herbicide antidotes | MONSANTO COMPANY (US) | 1989-08-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240317686-A1 | RORyT MODULATOR, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | RORC, RORB, RORA | OPRM1 3437/4885MAP4K4 3496/4885DRD2 4433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.